ArticleAnnals of surgical oncology2026
From Clinical Trial Awareness to Practice: Factors Associated with Intent to Omit Axillary Surgery Based on the SOUND Clinical Trial.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe SOUND trial, published in 2023, demonstrated the oncologic safety of sentinel lymph node biopsy (SLNB) for select patients with early-stage breast cancer. We evaluated whether earlier awareness of the results of the SOUND trial was associated with increased intent to implement SLNB omission.
methodsThis multicenter, cross-sectional study surveyed North American physicians on current SLNB use, awareness of the SOUND trial results, and intent to implement trial findings. Intent was measured using the Innovation-Specific Implementation Intentions scale and scenario-based questions (ages 50 vs 60; whole- vs partial-breast irradiation), on a 5-point scale. The primary outcome was high intent to omit SLNB ("moderate" to "very great" extent). Multiple logistic regression identified factors associated with intent.
resultsThe response rate was 21% (208/1004): 148 (71.5%) surgeons, 32 (13.04%) medical and 27 (15.46%) radiation oncologists. Overall, 47.8% had already omitted SLNB in select patients aged < 70 years, and 63.6% reported high intent to use SOUND results. Among those who had not yet omitted SLNB (n = 108), 59.3% had high intent. Length of awareness of the SOUND trial (odds ratio 1.13) and practicing in Northeast USA vs Western USA (odds ratio 3.45, p = 0.032) were associated with increased intent to omit SLNB. In scenario-based questions, most endorsed omission for a 60-year-old patient receiving whole-breast irradiation (n = 105 [50.5%]); willingness decreased for a 50 year old or when partial-breast irradiation was planned. Across scenarios, intent was not associated with SOUND awareness duration, clinician characteristics, or referral workflows.
conclusionsEarlier awareness of the SOUND trial and regional differences were associated with greater intent to omit SLNB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.